Our FUS-liquid biopsy project received funding from the ICTS

See the full report here https://icts.wustl.edu/icts-researchers/news-events/2256

Washington University Institute of Clinical and Translational Sciences (ICTS) awards 26 investigators with grants as part of the 12th annual Clinical and Translational Research Funding Program (CTRFP). The CTRFP is an internal grant funding program of the ICTS. Grant awardees are required to submit projects for funding that promote the translation of scientific discoveries into improvement in human health. For 2019, awards were considered across three categories: pilot grants, community-engaged research projects and innovative analytical methodology.

FOCUSED ULTRASOUND‐ENABLED BRAIN TUMOR LIQUID BIOPSY (FUS-LBX): DETECTING BRAIN CANCER WITHOUT A KNIFE

PI: Hong Chen, PhD, Assistant Professor, Washington University, Mckelvey School of Engineering and Applied Science: Biomedical Engineering; Washington University, School of Medicine: Radiation Oncology

We developed a novel technique – focused ultrasound-enabled brain tumor liquid biopsies – for noninvasive, localized, and safe brain tumor biopsies. This study will assess the potential of this technique for clinical translation. Data that will be obtained from this study will be used to support the investigational device exemption application to the FDA to start a clinical trial.

This project is funded by WU Institute of Clinical and Translational Sciences.